| SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology FP Veras, MC Pontelli, CM Silva, JE Toller-Kawahisa, M de Lima, ... Journal of Experimental Medicine 217 (12), e20201129, 2020 | 927 | 2020 |
| Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients TS Rodrigues, KSG de Sá, AY Ishimoto, A Becerra, S Oliveira, L Almeida, ... Journal of Experimental Medicine 218 (3), e20201707, 2020 | 820 | 2020 |
| Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial MI Lopes, LP Bonjorno, MC Giannini, NB Amaral, PI Menezes, SM Dib, ... RMD open 7 (1), e001455, 2021 | 235 | 2021 |
| Morphological, cellular, and molecular basis of brain infection in COVID-19 patients F Crunfli, VC Carregari, FP Veras, LS Silva, MH Nogueira, ASLM Antunes, ... Proceedings of the National Academy of Sciences 119 (35), e2200960119, 2022 | 228 | 2022 |
| PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation LEA Damasceno, DS Prado, FP Veras, MM Fonseca, JE Toller-Kawahisa, ... Journal of Experimental Medicine 217 (10), e20190613, 2020 | 196 | 2020 |
| Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation CMS Silva, CWS Wanderley, FP Veras, F Sonego, DC Nascimento, ... Blood, The Journal of the American Society of Hematology 138 (25), 2702-2713, 2021 | 162 | 2021 |
| SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability F Crunfli, VC Carregari, FP Veras, PH Vendramini, AGF Valença, ... MedRxiv, 2020.10. 09.20207464, 2021 | 93 | 2021 |
| Antagonization of IL-17A attenuates skin inflammation and vascular dysfunction in mouse models of psoriasis R Schüler, A Brand, S Klebow, J Wild, FP Veras, E Ullmann, S Roohani, ... Journal of Investigative Dermatology 139 (3), 638-647, 2019 | 77 | 2019 |
| Sepsis expands a CD39+ plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity DC Nascimento, PR Viacava, RG Ferreira, MA Damaceno, AR Piñeros, ... Immunity 54 (9), 2024-2041. e8, 2021 | 76 | 2021 |
| Infection of human lymphomononuclear cells by SARS-CoV-2 MC Pontelli, IA Castro, RB Martins, FP Veras, L La Serra, DC Nascimento, ... BioRxiv, 2020 | 70 | 2020 |
| Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of Th17 cells in the lymph nodes AL Saraiva, FP Veras, RS Peres, J Talbot, KA de Lima, JP Luiz, ... The FASEB Journal 32 (12), 6550-6558, 2018 | 69 | 2018 |
| Fructose 1, 6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway FP Veras, RS Peres, ALL Saraiva, LG Pinto, P Louzada-Junior, TM Cunha, ... Scientific reports 5 (1), 15171, 2015 | 58 | 2015 |
| Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology CMS Silva, CWS Wanderley, FP Veras, AV Gonçalves, MHF Lima, ... Critical Care 26 (1), 206, 2022 | 56 | 2022 |
| SARS-CoV-2 uses CD4 to infect T helper lymphocytes GG Davanzo, AC Codo, NS Brunetti, VO Boldrini, TL Knittel, LB Monterio, ... | 56* | 2020 |
| SARS-CoV-2 infects adipose tissue in a fat depot-and viral lineage-dependent manner TD Saccon, F Mousovich-Neto, RG Ludwig, VC Carregari, ... Nature Communications 13 (1), 5722, 2022 | 55 | 2022 |
| SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients MC Pontelli, ÍA Castro, RB Martins, L La Serra, FP Veras, DC Nascimento, ... Journal of Molecular Cell Biology 14 (4), mjac021, 2022 | 54 | 2022 |
| Enhancing untargeted metabolomics using metadata-based source annotation JM Gauglitz, KA West, W Bittremieux, CL Williams, KC Weldon, ... Nature biotechnology 40 (12), 1774-1779, 2022 | 51 | 2022 |
| Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells ACG Salina, D Dos-Santos, TS Rodrigues, M Fortes-Rocha, ... Elife 11, e74443, 2022 | 43 | 2022 |
| Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial MIF Lopes, LP Bonjorno, MC Giannini, NB Amaral, MN Benatti, UC Rezek, ... MedRxiv, 2020.08. 06.20169573, 2020 | 42 | 2020 |
| Neutrophil extracellular traps mediate joint hyperalgesia induced by immune inflammation AH Schneider, CC Machado, FP Veras, AGM Maganin, FFL de Souza, ... Rheumatology 60 (7), 3461-3473, 2021 | 40 | 2021 |